P

Inventor

SAUER GERHARD

DE65 patents
⚠️ This page may combine multiple inventors who share the name “SAUER GERHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

44 patents
US6958327B1Oct 25, 2005

18 Norsteroids as selectively active estrogens

SCHERING AG88 citations97
US4536401AAug 20, 1985

11β-aryl estradienes, processes for their production and pharmaceutical preparations containing them

SCHERING AG29 citations92
US5411966AMay 2, 1995

2, 13-disubstituted ergolines, their production and use in pharmaceutical agents

SCHERING AG22 citations90
US5401748AMar 28, 1995

2,14-disubstituted ergolines, their production and use in pharmaceutical compositions

SCHERING AG27 citations90
US6288051B1Sep 11, 2001

7 α-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 α(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents

SCHERING AG17 citations82
US5986115ANov 16, 1999

7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents

SCHERING AG16 citations82
US5547958AAug 20, 1996

N-(8α-ergolinyl)-amides

SCHERING AG17 citations81
US5212178AMay 18, 1993

8α-acylamino ergolines and use as pharmaceutical agents

SCHERING AG17 citations81
US5158957AOct 27, 1992

2-substituted ergolines

SCHERING AG19 citations81
US4970314ANov 13, 1990

Process for the preparation of 2-bromo-8-ergolinyl compounds

SCHERING AG19 citations81
US4968801ANov 6, 1990

Process for the production ergoline derivatives

SCHERING AG7 citations74
US4874768AOct 17, 1989

1,2-disubstituted ergolines useful for producing central antidopanminergic or α2-receptor-blocking activity

SCHERING AG15 citations74
US4826852AMay 2, 1989

Novel ergolinyl compounds nitrogen-substituted in the 8-position, useful for treating dopamine deficiency

SCHERING AG15 citations74
US4748248AMay 31, 1988

Process for the preparation of ergoline derivatives

SCHERING AG15 citations74
US4731367AMar 15, 1988

2-substituted ergolines useful as neuroleptics and antidepressants

SCHERING AG9 citations74
US4591585AMay 27, 1986

1-alkyl-androsta-1,4-diene-3,17-diones their production and pharmaceutical preparations containing same

SCHERING AG9 citations74
US6790842B1Sep 14, 2004

11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS

SCHERING AG7 citations73
US6767903B1Jul 27, 2004

New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases

SCHERING AG10 citations73
US6271403B1Aug 7, 2001

7α-(xi-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(xi-aminoalkyl-estratrienes as well as their use for the production of pharmaceutical agents

SCHERING AG7 citations73
US5866560AFeb 2, 1999

7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents

SCHERING AG14 citations73
US4379790AApr 12, 1983

(Erolinyl)-N,N-diethylurea derivatives, and their preparation and use

SCHERING AG16 citations73
US6780855B2Aug 24, 2004

11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS

SCHERING AG8 citations72
US4847262AJul 11, 1989

2-substituted ergolines having neuroleptic and antidepressant activities

SCHERING AG4 citations63
US4826851AMay 2, 1989

2-substituted ergoline urea and thio-urea derivatives having neurolyptic/dopaminergic activity

SCHERING AG5 citations63
US4695635ASep 22, 1987

Process for the production of 2,3-dihydroergolines

SCHERING AG2 citations63
US4417051ANov 22, 1983

Process for the preparation of 8α-substituted 6-methylergolines

SCHERING AG6 citations63
US4155923AMay 22, 1979

Process for the preparation of 17β-hydroxy-20-alkoxypregnane-21-oic acid derivatives

SCHERING AG2 citations63
US4077996AMar 7, 1978

Process for the preparation of trans-deca hydronaphthalene derivatives

SCHERING AG5 citations63
US4066674AJan 3, 1978

Process for the preparation of 1,3-oxygenated 8α-estratrienes and novel intermediates obtained therefrom

SCHERING AG6 citations63
US4024166AMay 17, 1977

Process for the preparation of 13β-alkyl-4-gonene-3,17-diones

SCHERING AG2 citations63
US5037832AAug 6, 1991

2-substituted ergolines

SCHERING AG3 citations62
US4766128AAug 23, 1988

Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents

SCHERING AG3 citations62
US4333928AJun 8, 1982

16 α-Alkyl steroids, their preparation, and pharmaceutical preparations thereof

SCHERING AG3 citations62
US4017545AApr 12, 1977

Process for the preparation of bicycloalkane derivatives

SCHERING AG5 citations62
US3960842AJun 1, 1976

Process for the preparation of 17β-oxalyl steroids

SCHERING AG3 citations62
US4863929ASep 5, 1989

12- and 13-substituted ergoline derivatives having alpha2 -receptor-blocking effect

SCHERING AG5 citations61
US4740509AApr 26, 1988

12- and 13-bromoergolines useful for treating hypertension

SCHERING AG6 citations61
US4170518AOct 9, 1979

Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use

SCHERING AG4 citations61
US4072716AFeb 7, 1978

Bicycloalkane derivatives

SCHERING AG2 citations61
US4178381ADec 11, 1979

C-homoestratrienes

SCHERING AG2 citations60
US5219862AJun 15, 1993

8 beta-substituted ergolines, process for their production and their use

SCHERING AG2 citations59
US4772610ASep 20, 1988

1-alkyl ergolinylthiourea derivatives and their use as antidepressant agents

SCHERING AG1 citations52
US4603013AJul 29, 1986

Estrane derivatives

SCHERING AG1 citations52
US4524208AJun 18, 1985

Process for the preparation of lysergic acid esters

SCHERING AG0 citations52

SAUER GERHARD

2 patents

CANCER RES VENTURES LTD

1 patent

MENZOLIT GMBH

1 patent

MERZ & CO GMBH & CO

1 patent

HOECHST AG

1 patent

Showing the top 50 of 65 patents by PatentIndex Score.